| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Atherosclerosis (peripheral vessels)CilostazoleAnkle arm indexAtherosclerosis (Carotids and Basilaris)Publication issuesInterleukin33NaftidrofurylCardiovascular riskStatinPhospholipid transfer proteinCoronary heart disease (BASKET)Mast cellsEndothelial dysfunctionMatrix metalloproteinaseBuflomedilReceptor (PPAR gamma)OxysterolUltrasound (intravascular)Thrombosis (BASKET)Receptor (oxLDL)Blood vessels (Physiology)Structure determination between tissue level and single molecule localization and molecular imagingPhospholipase A2MacrophagesUltrasound and DuplexsonographyHeme oxygenaseSphingosine1 phosphateProteasomeCD36SIRT1Optical coherence tomographyPain (Neurophysiology)Sudeck s DystrophyLow back painSpinal cord (Electrostimulation)HDLMyeloperoxidaseMonocytesSitosterolemia| 1 | 2000 | ABC of arterial and venous disease: Chronic lower limb ischaemia. | 
| + | - | nl | BMJ 320(7238):854-7 (2000) |
| 2 | 1992 | ABC of vascular diseases. Critical leg ischaemia: amputation or reconstruction. | 
| + | - | nl | BMJ 304(6822):312-4 (1992) |
| 3 | 2009 | Peripheral arterial disease: current perspectives and new trends in management. | 
| + | - | nl | South Med J 102(11):1141-9 (2009) |
| 4 | 2006 | Contemporary management of peripheral arterial disease: III. Endovascular and surgical management. | 
| + | - | nl | Cleve Clin J Med 73 Suppl 4(-):S45-51 (2006) |
| 5 | 2006 | Contemporary management of peripheral arterial disease: II. Improving walking distance and quality of life. | 
| + | - | nl | Cleve Clin J Med 73 Suppl 4(-):S38-44 (2006) |
| 6 | 2006 | Contemporary management of peripheral arterial disease: I. Cardiovascular risk-factor modification. | 
| + | - | nl | Cleve Clin J Med 73 Suppl 4(-):S30-7 (2006) |
| 7 | 2006 | Noninvasive diagnostic strategies for peripheral arterial disease. | 
| + | - | nl | Cleve Clin J Med 73 Suppl 4(-):S22-9 (2006) |
| 8 | 2006 | The clinical presentation of peripheral arterial disease and guidance for early recognition. | 
| + | - | nl | Cleve Clin J Med 73 Suppl 4(-):S15-21 (2006) |
| 9 | 2006 | Pathophysiology of peripheral arterial disease and risk factors for its development. | 
| + | - | nl | Cleve Clin J Med 73 Suppl 4(-):S8-14 (2006) |
| 10 | 2006 | Peripheral arterial disease: recognition and medical management. | 
| + | - | nl | Cleve Clin J Med 73(7):621-6, 628, 632-4, passim (2006) |
| 11 | 2008 | Management of peripheral arterial disease in the elderly: focus on cilostazol. | 
| + | - | nl | Clin Interv Aging 3(1):17-23 (2008) |
| 12 | 2008 | Critical review of the ankle brachial index. | 
| + | - | nl | Curr Cardiol Rev 4(2):101-6 (2008) |
| 13 | 2000 | Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). | 
| + | - | nl | J Vasc Surg 31(1 Pt 2):S1-S296 (2000) |
| 14 | 2009 | Primary nitinol stenting for femoropopliteal disease. | 
| + | - | nl | J Endovasc Ther 16(2 Suppl 2):II63-81 (2009) |
| 15 | 2009 | Medical and endovascular management of critical limb ischemia. | 
| + | - | nl | J Endovasc Ther 16(2 Suppl 2):II31-62 (2009) |
| 16 | 2009 | TASC II and the endovascular management of infrainguinal disease. | 
| + | - | nl | J Endovasc Ther 16(2 Suppl 2):II5-18 (2009) |
| 17 | 2009 | Past, present and future of femoropopliteal stenting. | 
| + | - | nl | J Endovasc Ther 16 Suppl 1(-):I147-52 (2009) |
| 18 | 2009 | Infrapopliteal stents: overview and unresolved issues. | 
| + | - | nl | J Endovasc Ther 16 Suppl 1(-):I153-62 (2009) |
| 19 | 2006 | Contemporary endovascular treatment for disease of the superficial femoral and popliteal arteries: an integrated device-based strategy. | 
| + | - | nl | J Endovasc Ther 13 Suppl 2(-):II41-51 (2006) |
| 20 | 2006 | Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. | 
| + | - | nl | J Endovasc Ther 13 Suppl 2(-):II30-40 (2006) |
| 21 | 2006 | Diagnosis and risk assessment of lower extremity peripheral arterial disease. | 
| + | - | nl | J Endovasc Ther 13 Suppl 2(-):II10-8 (2006) |
| 22 | 2006 | Epidemiology and pathophysiology of lower extremity peripheral arterial disease. | 
| + | - | nl | J Endovasc Ther 13 Suppl 2(-):II3-9 (2006) |
| 23 | 2003 | Percutaneous transluminal angioplasty in the treatment of critical limb ischemia. | 
| + | - | nl | J Endovasc Ther 10(2):298-303 (2003) |
| 24 | 2000 | The role of thrombolytic therapy in the management of acute and chronic lower extremity ischemia. | 
| + | - | nl | J Endovasc Ther 7(1):72-7 (2000) |
| 25 | 1999 | Percutaneous transluminal angioplasty of the subclavian arteries. | 
| + | - | nl | J Endovasc Surg 6(1):33-41 (1999) |
| 26 | 2007 | Risk reduction with clopidogrel in the management of peripheral arterial disease. | 
| + | - | nl | Vasc Health Risk Manag 3(3):289-97 (2007) |
| 27 | 2007 | A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. | 
| + | - | nl | Health Technol Assess 11(20):iii-iv, xi-xiii, 1-184 (2007) |
| 28 | 2002 | The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review. | 
| + | - | nl | Health Technol Assess 6(7):1-155 (2002) |
| 29 | 2007 | Peripheral arterial disease: a guide for nephrologists. | 
| + | - | nl | Clin J Am Soc Nephrol 2(4):839-46 (2007) |
| 30 | 1991 | Selection of level for lower limb amputation in patients with severe peripheral vascular disease. | 
| + | - | nl | Ann R Coll Surg Engl 73(3):148-51 (1991) |
| 31 | 1992 | Endovascular surgery for peripheral arterial occlusive disease. A critical review. | 
| + | - | nl | Ann Surg 216(1):3-16 (1992) Ahn SS |
| 32 | 1982 | Axillofemoral bypass: a ten-year review. | 
| + | - | nl | Ann Surg 195(6):796-9 (1982) |
| 33 | 1965 | Review of Criteria for the Selection of the Level for Lower Extremity Amputation for Arteriosclerosis. | 
| + | - | nl | Ann Surg 162(5):886-92 (1965) |
| 34 | 2009 | ACP Journal Club. Review: computed tomography angiography is highly accurate for diagnosing significant stenosis in peripheral arterial disease. | 
| + | - | nl | Ann Intern Med 150(10):JC5-12 (2009) |
| 35 | 2007 | In the clinic. Peripheral arterial disease. | 
| + | - | nl | Ann Intern Med 146(5):ITC3-1-ITC3-16 (2007) |
| 36 | 2008 | Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | 
| + | - | nl | Chest 133(6 Suppl):815S-843S (2008) |
| 37 | 2008 | Atherosclerotic Peripheral Vascular Disease Symposium II: lower-extremity revascularization: state of the art. | 
| + | - | nl | Circulation 118(25):2864-72 (2008) |
| 38 | 2008 | Atherosclerotic Peripheral Vascular Disease Symposium II: vascular magnetic resonance and computed tomographic imaging. | 
| + | - | nl | Circulation 118(25):2837-44 (2008) |
| 39 | 2007 | Endovascular therapies for peripheral arterial disease: an evidence-based review. | 
| + | - | nl | Circulation 116(19):2203-15 (2007) |
| 40 | 2007 | Overview of new technologies for lower extremity revascularization. | 
| + | - | nl | Circulation 116(18):2072-85 (2007) |
| 41 | 2006 | Peripheral arterial disease: morbidity and mortality implications. | 
| + | - | nl | Circulation 114(7):688-99 (2006) |
| 42 | 2006 | ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. | 
| + | - | nl | Circulation 113(11):e463-654 (2006) |
| 43 | 1996 | Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. | 
| + | - | nl | Circulation 94(11):3026-49 (1996) |
| 44 | 1995 | Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. | 
| + | - | nl | Circulation 92(3):614-21 (1995) |
| 45 | 2009 | Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. | 
| + | - | nl | Eur Heart J 30(1):44-55 (2009) |
| 46 | 2001 | Lower-extremity peripheral arterial disease among patients with end-stage renal disease. | 
| + | - | nl | J Am Soc Nephrol 12(12):2838-47 (2001) |
| 47 | 2009 | Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. | 
| + | - | nl | JAMA 301(4):415-24 (2009) |
| 48 | 2006 | Medical treatment of peripheral arterial disease. | 
| + | - | nl | JAMA 295(5):547-53 (2006) |
| 49 | 2001 | Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. | 
| + | - | nl | JAMA 285(10):1338-45 (2001) |
| 50 | 2008 | Peripheral arterial disease: diagnosis and management. | 
| + | - | nl | Mayo Clin Proc 83(8):944-49; quiz 949-50 (2008) |
| 51 | 1994 | Treatment of the critically ischaemic lower limb. | 
| + | - | nl | Postgrad Med J 70(819):5-9 (1994) |
| 52 | 1987 | Angioplasty in peripheral vascular disease. | 
| + | - | nl | Postgrad Med J 63(740):435-8 (1987) |
| 53 | 2000 | Update on endovascular treatment of peripheral vascular disease: new tools, techniques, and indications. | 
| + | - | nl | Tex Heart Inst J 27(4):369-85 (2000) |
| 54 | 2000 | Current concepts in the evaluation of vascular disease: magnetic resonance and computed tomographic angiography. | 
| + | - | nl | Tex Heart Inst J 27(2):170-92 (2000) |
| 55 | 2000 | State of the art: which stent for which lesion in peripheral interventions? | 
| + | - | nl | Tex Heart Inst J 27(2):119-26 (2000) |
| 56 | 2000 | Chronic lower limb ischemia. | 
| + | - | nl | West J Med 173(1):60-3 (2000) |
| 57 | 2007 | Current treatment of peripheral arterial disease: role of percutaneous interventional therapies. | 
| + | - | nl | J Am Coll Cardiol 50(6):473-90 (2007) |
| 58 | 2006 | ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. | 
| + | - | nl | J Am Coll Cardiol 47(6):1239-312 (2006) |
| 59 | 2004 | The role of infrapopliteal angioplasty. | 
| + | - | nl | Br J Radiol 77(924):1007-15 (2004) |
| 60 | 2008 | MR angiography of the lower extremities. | 
| + | - | nl | AJR Am J Roentgenol 190(6):1675-84 (2008) |
| 61 | 2005 | Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography. | 
| + | - | nl | AJR Am J Roentgenol 185(6):1641-50 (2005) |
| 62 | 2000 | Diabetes and peripheral arterial occlusive disease: prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography. | 
| + | - | nl | AJR Am J Roentgenol 174(1):171-9 (2000) |
| 63 | 2008 | Multidetector CT angiography of infrainguinal arterial bypass. | 
| + | - | nl | Radiographics 28(2):529-48; discussion 549 (2008) |
| 64 | 2004 | Popliteal artery disease: diagnosis and treatment. | 
| + | - | nl | Radiographics 24(2):467-79 (2004) |
| 65 | 2000 | Optimized diagnostic angiography in high-risk patients with severe peripheral vascular disease. | 
| + | - | nl | Radiographics 20(1):121-33 (2000) |
| 66 | 2005 | Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis. | 
| + | - | nl | Radiology 235(2):699-708 (2005) |
| 67 | 2000 | MR angiography in the evaluation of atherosclerotic peripheral vascular disease. | 
| + | - | nl | Radiology 214(2):325-38 (2000) |
| 68 | 1997 | Treatment of peripheral vascular disease with stent-grafts. | 
| + | - | nl | Radiology 205(2):307-14 (1997) |
| 69 | 2007 | The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. | 
| + | - | nl | Acta Med Indones 39(2):86-93 (2007) |
| 70 | 2010 | The counter-regulation of atherogenesis: a role for interleukin-33. | 
| + | - | nl | Acta Medica (Hradec Kralove) 53(3):125-9 (2010) |
| 71 | 2010 | Vascular calcification in animal models of CKD: A review. | 
| + | - | nl | Am J Nephrol 31(6):471-81 (2010) |
| 72 | 2008 | Novel therapies for cyclic GMP control of vascular smooth muscle growth. | 
| + | - | nl | Am J Ther 15(6):551-64 (2008) |
| 73 | 2004 | Osteogenic regulation of vascular calcification: an early perspective. | 
| + | - | nl | Am J Physiol Endocrinol Metab 286(5):E686-96 (2004) |
| 74 | 2006 | Intermittent claudication. | 
| + | - | nl | BMJ 333(7576):1002-5 (2006) |
| 75 | 2009 | Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data. | 
| + | - | nl | BMJ 338(-):b603 (2009) |
| 76 | 2008 | Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability. | 
| + | - | nl | Biochim Biophys Acta 1781(5):221-31 (2008) |
| 77 | 2007 | Bilirubin and biliverdin treatment of atherosclerotic diseases. | 
| + | - | nl | Cell Cycle 6(1):39-43 (2007) |
| 78 | 2005 | Conditional risk factors for atherosclerosis. | 
| + | - | nl | Mayo Clin Proc 80(2):219-30 (2005) |
| 79 | 2002 | Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis. | 
| + | - | nl | J Am Soc Nephrol 13(6):1673-81 (2002) |
| 80 | 2009 | Vascular calcification: the three-hit model. | 
| + | - | nl | J Am Soc Nephrol 20(6):1162-4 (2009) Moe SM |
| 81 | 2006 | Neovascularization in human atherosclerosis. | 
| + | - | nl | Circulation 113(18):2245-52 (2006) |
| 82 | 2010 | Phospholipid transfer protein and atherosclerosis: genetic studies take aim at a moving target. | 
| + | - | nl | Circulation 122(5):452-4 (2010) |
| 83 | 2010 | Inflammation in peripheral artery disease. | 
| + | - | nl | Circulation 122(18):1862-75 (2010) |
| 84 | 2003 | From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. | 
| + | - | nl | Circulation 108(14):1664-72 (2003) |
| 85 | 2003 | From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. | 
| + | - | nl | Circulation 108(15):1772-8 (2003) |
| 86 | 2003 | Membrane microdomains and vascular biology: emerging role in atherogenesis. | 
| + | - | nl | Circulation 107(17):2270-3 (2003) |
| 87 | 2007 | Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. | 
| + | - | nl | Circulation 116(16):1832-44 (2007) |
| 88 | 2007 | Mast cells as mediators and modulators of atherogenesis. | 
| + | - | nl | Circulation 115(19):2471-3 (2007) Libby P |
| 89 | 2005 | Childhood infection and endothelial dysfunction: a potential link in atherosclerosis? | 
| + | - | nl | Circulation 111(13):1568-70 (2005) Napoli C |
| 90 | 2009 | Insights into the role of infection in atherogenesis and in plaque rupture. | 
| + | - | nl | Circulation 119(24):3133-41 (2009) |
| 91 | 2008 | Bone-marrow-derived matrix metalloproteinase-14: a novel target for plaque stability. | 
| + | - | nl | Circulation 117(7):863-5 (2008) Shimokawa H |
| 92 | 2008 | Buflomedil in peripheral arterial disease: trials and tribulations. | 
| + | - | nl | Circulation 117(6):717-9 (2008) Conte MS |
| 93 | 2010 | Understanding the essential role of monocytes in atherosclerosis. | 
| + | - | nl | Circ J 74(7):1292-3 (2010) Kimura S |
| 94 | 2011 | Role of peroxisome proliferator-activated receptor-γ in atherosclerosis: an update. | 
| + | - | nl | Circ J 75(3):528-35 (2011) |
| 95 | 2011 | Advances in endovascular treatment of critical limb ischemia. | 
| + | - | nl | Circ J 75(4):756-65 (2011) |
| 96 | 2010 | Macrophages, oxysterols and atherosclerosis. | 
| + | - | nl | Circ J 74(10):2045-51 (2010) |
| 97 | 2009 | Critical balance of dendritic cells is destined for plaque rupture. | 
| + | - | nl | Circ J 73(10):1799-800 (2009) |
| 98 | 2009 | Serial intravascular ultrasound assessment of atherosclerosis progression and regression. State-of-the-art and limitations. | 
| + | - | nl | Circ J 73(9):1557-60 (2009) |
| 99 | 2007 | Targeting interferon-gamma to treat atherosclerosis. | 
| + | - | nl | Circ Res 101(4):333-4 (2007) Gotsman I |
| 100 | 2007 | Selective depletion of macrophages in atherosclerotic plaques: myth, hype, or reality? | 
| + | - | nl | Circ Res 100(6):751-3 (2007) Martinet W |
| 101 | 2011 | Atherosclerosis and thrombosis: insights from large animal models. | 
| + | - | nl | J Biomed Biotechnol 2011(-):907575 (2011) |
| 102 | 2010 | Microregulation of plaque neovascularization. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 30(8):1500-1 (2010) Suarez Y |
| 103 | 2010 | Concept of vulnerable/unstable plaque. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 30(7):1282-92 (2010) |
| 104 | 2005 | Lesion macrophages are a key target for the antiatherogenic effects of LXR agonists. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 25(1):10-1 (2005) Bradley MN |
| 105 | 2009 | Discovery of the role of wall shear in atherosclerosis. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 29(2):158-61 (2009) |
| 106 | 2007 | Mouse models for atherosclerosis and pharmaceutical modifiers. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 27(8):1706-21 (2007) |
| 107 | 2009 | Inflammation imaging in atherosclerosis. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 29(7):1009-16 (2009) |
| 108 | 2007 | Assessment of unstable atherosclerosis in mice. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 27(4):714-20 (2007) |
| 109 | 2007 | Plaque rupture in humans and mice. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 27(4):705-13 (2007) |
| 110 | 2007 | PLA2-V: a real player in atherogenesis. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 27(3):445-7 (2007) Oorni K |
| 111 | 2005 | Role of caspases in death and survival of the plaque macrophage. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 25(5):895-903 (2005) |
| 112 | 2009 | Molecular imaging of macrophage cell death for the assessment of plaque vulnerability. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 29(7):1031-8 (2009) |
| 113 | 2010 | Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 30(2):177-81 (2010) |
| 114 | 2005 | Heme oxygenase and atherosclerosis. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 25(9):1786-95 (2005) |
| 115 | 2009 | The discovery of cellular immunity in the atherosclerotic plaque. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 29(11):1714-7 (2009) |
| 116 | 2009 | Sphingosine 1-phosphate: a regulator of arterial lesions. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 29(10):1439-43 (2009) |
| 117 | 2008 | Role of smooth muscle cells in the initiation and early progression of atherosclerosis. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 28(5):812-9 (2008) |
| 118 | 2010 | On to the road to degradation: atherosclerosis and the proteasome. | 
| + | - | nl | Cardiovasc Res 85(2):291-302 (2010) |
| 119 | 2007 | CD36 and macrophages in atherosclerosis. | 
| + | - | nl | Cardiovasc Res 75(3):468-77 (2007) |
| 120 | 2007 | Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability. | 
| + | - | nl | Cardiovasc Res 73(3):470-80 (2007) |
| 121 | 2008 | Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans. | 
| + | - | nl | Cardiovasc Res 79(1):14-23 (2008) |
| 122 | 2008 | Activating SIRT1: a new strategy to prevent atherosclerosis? | 
| + | - | nl | Cardiovasc Res 80(2):163-4 (2008) Brandes RP |
| 123 | 2009 | The unstable plaque: a broken balance. | 
| + | - | nl | Eur Heart J 30(15):1821-3 (2009) Crea F |
| 124 | 2009 | Imaging of the unstable plaque: how far have we got? | 
| + | - | nl | Eur Heart J 30(21):2566-74 (2009) |
| 125 | 2006 | Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. | 
| + | - | nl | Stroke 37(7):1923-32 (2006) |
| 126 | 2010 | From endothelial dysfunction to vascular occlusion: role of the renin-angiotensin system. | 
| + | - | nl | Rev Port Cardiol 29(5):801-24 (2010) |
| 127 | 2004 | Footprints of atherosclerotic coronary heart disease in children. | 
| + | - | nl | Rev Port Cardiol 23(1):127-31 (2004) |
| 128 | 2009 | Endothelial function and atherosclerosis: circulatory markers with clinical usefulness. | 
| + | - | nl | Rev Port Cardiol 28(10):1121-51 (2009) |
| 129 | 2002 | Spinal cord stimulation. | 
| + | - | nl | Pain Physician 5(2):156-66 (2002) |
| 130 | 2010 | The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? | 
| + | - | nl | J Lipid Res 51(8):2058-73 (2010) |
| 131 | 2009 | The LDL modification hypothesis of atherogenesis: an update. | 
| + | - | nl | J Lipid Res 50 Suppl(-):S376-81 (2009) |
| 132 | 2005 | Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis. | 
| + | - | nl | J Lipid Res 46(3):404-11 (2005) |
| 133 | 2005 | Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis. | 
| + | - | nl | J Lipid Res 46(5):829-38 (2005) |
| 134 | 2009 | Myeloperoxidase, modified lipoproteins, and atherogenesis. | 
| + | - | nl | J Lipid Res 50 Suppl(-):S346-51 (2009) |
| 135 | 2009 | The role of adaptive T cell immunity in atherosclerosis. | 
| + | - | nl | J Lipid Res 50 Suppl(-):S364-9 (2009) |
| 136 | 2009 | Mechanisms and consequences of macrophage apoptosis in atherosclerosis. | 
| + | - | nl | J Lipid Res 50 Suppl(-):S382-7 (2009) |
| 137 | 2009 | The role of dysfunctional HDL in atherosclerosis. | 
| + | - | nl | J Lipid Res 50 Suppl(-):S145-9 (2009) |
| 138 | 2009 | Emerging role of Toll-like receptors in atherosclerosis. | 
| + | - | nl | J Lipid Res 50 Suppl(-):S340-5 (2009) |
| 139 | 2011 | Immune mechanisms in atherosclerosis and potential for an atherosclerosis vaccine. | 
| + | - | nl | Discov Med 11(60):403-12 (2011) |
| 140 | 2003 | Role of monocytes in atherogenesis. | 
| + | - | nl | Physiol Rev 83(4):1069-112 (2003) |
| 141 | 2007 | Autophagy of vascular smooth muscle cells in atherosclerotic lesions. | 
| + | - | nl | Autophagy 3(1):63-4 (2007) |
| 142 | 2007 | A two-carbon switch to sterol-induced autophagic death. | 
| + | - | nl | Autophagy 3(1):38-41 (2007) |
| 143 | 2007 | Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis. | 
| + | - | nl | Cell Adh Migr 1(4):171-5 (2007) |
| 144 | 2008 | Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. | 
| + | - | nl | Clin Chem 54(1):24-38 (2008) |
| 145 | 2004 | Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications. | 
| + | - | nl | Med J Aust 181(3):150-4 (2004) |
| 146 | 2008 | The role of inflammation, humoral and cell mediated autoimmunity in the pathogenesis of atherosclerosis. | 
| + | - | nl | Swiss Med Wkly 138(37-38):534-9 (2008) |
| 147 | 2007 | Role of infrainguinal angioplasty in the treatment of critical limb ischaemia. | 
| + | - | nl | Scand J Surg 96(1):11-6 (2007) |
| 148 | 2004 | Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents. | 
| + | - | nl | J Appl Physiol 97(2):773-80 (2004) |